![Genentech faces 'generic' challenge from Amgen (NASDAQ: AMGN) and Allergan (NYSE: AGN) to cancer drug Avastin - San Francisco Business Times Genentech faces 'generic' challenge from Amgen (NASDAQ: AMGN) and Allergan (NYSE: AGN) to cancer drug Avastin - San Francisco Business Times](http://media.bizj.us/view/img/333831/avastinbottle2*750xx558-744-0-20.jpg)
Genentech faces 'generic' challenge from Amgen (NASDAQ: AMGN) and Allergan (NYSE: AGN) to cancer drug Avastin - San Francisco Business Times
![Avastin 100mg Injection Price-Side-Effects, Uses,Dosage, Generic-Alternatives in India-Uses of Avastin 100mg Injection Avastin 100mg Injection Price-Side-Effects, Uses,Dosage, Generic-Alternatives in India-Uses of Avastin 100mg Injection](https://www.indiangenericmedicines.com/wp-content/uploads/2019/02/Avastin_Front-208x300.jpeg)
Avastin 100mg Injection Price-Side-Effects, Uses,Dosage, Generic-Alternatives in India-Uses of Avastin 100mg Injection
![Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial - ScienceDirect Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149291820301739-gr1.jpg)
Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial - ScienceDirect
![Cheap blindness drug should be made widely available, says WHO | Blindness and visual impairment | The Guardian Cheap blindness drug should be made widely available, says WHO | Blindness and visual impairment | The Guardian](https://i.guim.co.uk/img/static/sys-images/Guardian/Pix/pictures/2015/5/17/1431879173440/51e1d959-b4f1-496e-8a05-2edccde6dcf7-2060x1236.jpeg?width=465&quality=85&dpr=1&s=none)